Hydra Biosciences Obtains $17,016,100 Series C Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=eef20686-50dd-4de8-abe3-8efe6e58aeba&Preview=1 -
Date
3/13/2008 -
Company Name
Hydra Biosciences -
Mailing Address
790 Memorial Drive Cambridge, MA 02139 -
Company Description
Hydra Biosciences is a biopharmaceutical company developing molecular regeneration medicines, novel cardiovascular therapies and drugs targeting novel ion channels. -
Website
http://www.hydrabiosciences.com -
Transaction Type
Venture Equity -
Transaction Amount
$17,016,100 -
Transaction Round
Series C -
Proceeds Purposes
Proceeds purposes were not disclosed. This is the final tranche of a series C round totaling $34 million. -
M&A Terms
-
Venture Investor
Advanced Technology Ventures -
Venture Investor
Abingworth Management Inc -
Venture Investor
Bioventures Investors -
Venture Investor
Lilly Ventures -
Venture Investor
New Enterprise Associates -
Venture Investor
Polaris Venture Partners
